The intracellular region of truncated neurotrophin receptor TrkB-T1 is sufficient to promote brain glial reactivity, neuroinflammation and neurotoxicity

Abstract The development of advanced therapies for stroke, spinal cord injury, and neurodegenerative diseases—primary causes of death, disability and dementia—requires a comprehensive understanding of the interplay between excitotoxicity, aberrant neurotrophic-signalling, glial reactivity, and neuroinflammation. Recent evidence has identified the truncated neurotrophin receptor TrkB-T1 as a potential master regulator of these processes. TrkB-T1 levels increase after stroke whereas the pro-survival full-length isoform (TrkB-FL) decreases. Furthermore, stroke-induced excitotoxicity triggers TrkB-T1 regulated intramembrane proteolysis (RIP), which produces TrkB-T1-ICD, a poorly characterised fragment containing the receptor intracellular domain and a few transmembrane amino acids. This study investigated whether the TrkB-T1 intracellular domain intrinsically contributes to neurotoxicity, reactive gliosis, and neuroinflammation. Our results predict that TrkB-T1 RIP generates a nuclear localization signal in TrkB-T1-ICD that might support nuclear translocation and injury-induced transcriptional regulation in neurons undergoing excitotoxicity. Using cell-penetrating peptides (CPPs), we generated a TrkB-T1-ICD mimetic peptide (Bio-LTT1 Ct ) containing the TrkB-T1 intracellular region. Bio-LTT1 Ct translocated to the nucleus of neurons and astrocytes, provoking cell death and inducing early transcriptional changes in neurons, resembling those triggered by excitotoxicity. In vivo, intranasally administrated Bio-LTT1 Ct was brain-permeable and distributed within cortical neurons and astrocytes across both hemispheres. Notably, Bio-LTT1 Ct administration was sufficient to promote TrkB isoform imbalance, glial reactivity, and acquisition of proinflammatory profiles, all considered stroke hallmarks. In conclusion, these results imply that TrkB-T1 RIP might be a central mechanism of ischaemic damage and identify the receptor’s intracellular region as sufficient to recapitulate stroke-like effects, marking this pathological mechanism as a critical target for therapy.

Authors

Institutions

Publication Details

Journal
Molecular Biomedicine
Published
2026-11-13
DOI
https://doi.org/10.1186/s43556-026-00650-x
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The intracellular region of truncated neurotrophin receptor TrkB-T1 is sufficient to promote brain glial reactivity, neuroinflammation and neurotoxicity

Margarita Díaz‐Guerra, María Concepción Serrano, Lola Ugalde‐Triviño
2 links
Molecular Biomedicine
Neuroinflammation and Neurodegeneration Mechanisms
article

The intracellular region of truncated neurotrophin receptor TrkB-T1 is sufficient to promote brain glial reactivity, neuroinflammation and neurotoxicity

Margarita Díaz‐Guerra, María Concepción Serrano, Lola Ugalde‐Triviño
article en

Abstract

Abstract The development of advanced therapies for stroke, spinal cord injury, and neurodegenerative diseases—primary causes of death, disability and dementia—requires a comprehensive understanding of the interplay between excitotoxicity, aberrant neurotrophic-signalling, glial reactivity, and neuroinflammation. Recent evidence has identified the truncated neurotrophin receptor TrkB-T1 as a potential master regulator of these processes. TrkB-T1 levels increase after stroke whereas the pro-survival full-length isoform (TrkB-FL) decreases. Furthermore, stroke-induced excitotoxicity triggers TrkB-T1 regulated intramembrane proteolysis (RIP), which produces TrkB-T1-ICD, a poorly characterised fragment containing the receptor intracellular domain and a few transmembrane amino acids. This study investigated whether the TrkB-T1 intracellular domain intrinsically contributes to neurotoxicity, reactive gliosis, and neuroinflammation. Our results predict that TrkB-T1 RIP generates a nuclear localization signal in TrkB-T1-ICD that might support nuclear translocation and injury-induced transcriptional regulation in neurons undergoing excitotoxicity. Using cell-penetrating peptides (CPPs), we generated a TrkB-T1-ICD mimetic peptide (Bio-LTT1 Ct ) containing the TrkB-T1 intracellular region. Bio-LTT1 Ct translocated to the nucleus of neurons and astrocytes, provoking cell death and inducing early transcriptional changes in neurons, resembling those triggered by excitotoxicity. In vivo, intranasally administrated Bio-LTT1 Ct was brain-permeable and distributed within cortical neurons and astrocytes across both hemispheres. Notably, Bio-LTT1 Ct administration was sufficient to promote TrkB isoform imbalance, glial reactivity, and acquisition of proinflammatory profiles, all considered stroke hallmarks. In conclusion, these results imply that TrkB-T1 RIP might be a central mechanism of ischaemic damage and identify the receptor’s intracellular region as sufficient to recapitulate stroke-like effects, marking this pathological mechanism as a critical target for therapy.

Molecular BiomedicineVol. 7(1)
Consejo Superior de Investigaciones Científicas (ES), Instituto de Investigaciones Biomédicas Sols-Morreale (ES), Instituto de Ciencia de Materiales de Madrid (ES), Universidad Autónoma de Madrid (ES)
Universidad Autónoma de Madrid, Agencia Estatal de Investigación, Centro Nacional de Biotecnología, Ministerio de Universidades
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon